Cargando…
Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers
Worldwide, the incidence rate of breast cancer is the highest in women. Approximately 2.3 million people were newly diagnosed and 0.685 million were dead of breast cancer in 2020, which continues to grow. Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype with a higher...
Autores principales: | Cui, Yingshu, Xu, Yuanyuan, Li, Yi, Sun, Yuanyuan, Hu, Jia, Jia, Jia, Li, Xiaosong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903039/ https://www.ncbi.nlm.nih.gov/pubmed/36734039 http://dx.doi.org/10.1177/15330338221145992 |
Ejemplares similares
-
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
por: Fukushima, Hiroshi, et al.
Publicado: (2022) -
Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment
por: Burley, Thomas A., et al.
Publicado: (2018) -
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts
por: Furumoto, Hideyuki, et al.
Publicado: (2022) -
Avoiding thermal injury during near-infrared photoimmunotherapy (NIR-PIT): the importance of NIR light power density
por: Okuyama, Shuhei, et al.
Publicado: (2017) -
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin
por: Inagaki, Fuyuki F., et al.
Publicado: (2022)